Cancer staging and survival in colon cancer is dependent on the quality of the pathologists’ specimen examination

This publication has 29 references indexed in Scilit:

• Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?
  Journal of Clinical Oncology, 2004
• Quality assurance in surgical oncology. Colorectal cancer as an example
  European Journal of Surgical Oncology, 2003
• Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands
  British Journal of Surgery, 2002
• A National Strategic Change in Treatment Policy for Rectal Cancer—Implementation of Total Mesorectal Excision as Routine Treatment in Norway. A National Audit
  Diseases of the Colon & Rectum, 2002
• Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III
  British Journal of Cancer, 2001
• A Systematic Overview of Chemotherapy Effects in Colorectal Cancer
  Acta Oncologica, 2001
• Changing strategy for rectal cancer is associated with improved outcome
  British Journal of Surgery, 1999
• Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy
  British Journal of Surgery, 1997
• Clinicopathological staging for colorectal cancer: An International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT)
  Journal of Gastroenterology and Hepatology, 1991
• The classification of cancer of the rectum
  The Journal of Pathology and Bacteriology, 1932